Erythropoiesis-stimulating Agent [EPC]

54073 reported adverse events

Drugs of this class: DARBEPOETIN ALFA

These side effects are most commonly reported by patients taking drugs of the Erythropoiesis-stimulating Agent [EPC] class:

# Side effect Count
0 DEATH 16296
1 HOSPITALISATION 6211
2 OFF LABEL USE 2624
3 ANAEMIA 2197
4 HAEMOGLOBIN DECREASED 1664
5 PRODUCT STORAGE ERROR 1623
6 PNEUMONIA 1504
7 FATIGUE 1491
8 DYSPNOEA 1458
9 DIARRHOEA 1339
See all common reactions for Erythropoiesis-stimulating Agent [EPC]

Drugs of the Erythropoiesis-stimulating Agent [EPC] class are most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 APPENDICOLITH 290 0.7494
1 SLEEP DISORDER THERAPY 125 0.6313
2 SHUNT STENOSIS 134 0.4838
3 ANTI-ERYTHROPOIETIN ANTIBODY POSITIVE 120 0.4781
4 ANALGESIC THERAPY 138 0.4299
5 DRUG THERAPY 135 0.3982
6 ARTERIOVENOUS FISTULA SITE COMPLICATION 238 0.3967
7 APLASIA PURE RED CELL 808 0.2346
8 PERITONEAL DIALYSIS 174 0.2104
9 SHUNT OCCLUSION 106 0.2087
See all enriched reactions for Erythropoiesis-stimulating Agent [EPC]